MA Boston의 전립선암 임상 시험
전립선암 관련 연구 60개가 Boston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
피험자 모집 중4상
- Massachusetts General Hospital, Boston
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
피험자 모집 중
- Dana Farber Cancer Institute, Boston
Precision-Based Genomics in Prostate Cancer
피험자 모집 중관찰 연구
- Dana Farber Cancer Institute, Boston, MA, Boston
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
피험자 모집 중1/2상
- Dana Farber Mass General Brigham Cancer Care Inc, Boston
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
피험자 모집 중1/2상
- Research Site, Boston
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- Harvard Medical School-Massachusetts General Hospital, Boston
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
피험자 모집 중1상
- Mass General Hospital, Boston
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
피험자 모집 중2/3상
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
피험자 모집 중3상
- Beth Israel Deaconess Med Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
CV CARE: CardioVascular Care in PC Patients
피험자 모집 중
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
피험자 모집 중3상
- Beth Israel Deaconess Medical Center ( Site 0043), Boston
- Dana Farber Cancer Institute ( Site 0012), Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
피험자 모집 중3상
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
피험자 모집 중
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Serial MRI Scans During Radiation Therapy
피험자 모집 중
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prostate Active Surveillance Study
피험자 모집 중관찰 연구
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
피험자 모집 중2상
- Dana Farber Cancer Institute, Boston
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
피험자 모집 중2상
- Brigham and Women's Hospital, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
피험자 모집 중2상
- Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center, Boston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
피험자 모집 중1/2상
- Research Site, Boston
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
피험자 모집 중1/2상
- Research Site, Boston
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
피험자 모집 중2상
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
피험자 모집 중
- Dana Farber Cancer Institute, Boston
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
피험자 모집 중3상
- Dana-Farber Cancer Institute, Boston
Jump: MR Simulation For Radiation Therapy Master Protocol
피험자 모집 중
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
Androgen-responsive POSLUMA-guided Intra-prostatic Boost
피험자 모집 중2상
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Video Education With Result Dependent dIsclosure
피험자 모집 중
- Dana Farber Cancer Institute, Boston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
피험자 모집 중관찰 연구
- Dana-Farber Cancer Institute, Boston
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
피험자 모집 중3상
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
피험자 모집 중관찰 연구건강한 지원자 환영
- Massachusetts General Hospital, Boston
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- Research Site, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Clinical Trial of Approaches to Prostate Cancer Surgery
피험자 모집 중
- Beth Israel Deaconess Medical Center (BIDMC), Boston
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
피험자 모집 중2/3상
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Study of AZD0754 in Participants With Metastatic Prostate Cancer
피험자 모집 중1/2상
- Research Site, Boston
- Research Site, Boston
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
피험자 모집 중4상
- Dana Farber Cancer Institute, Boston
- Brigham and Womens Hospital, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
피험자 모집 중4상
- Massachussets General Hospital, Boston
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
피험자 모집 중건강한 지원자 환영
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
MRI Guided Prostate Biopsy
피험자 모집 중
- Brigham and Women's Hospital, Boston
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
피험자 모집 중관찰 연구
- Massachsuetts General Hospital, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
피험자 모집 중
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
피험자 모집 중건강한 지원자 환영
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
- Brigham and Womens Hospital, Boston
Comprehensive Outcomes for After Cancer Health
피험자 모집 중건강한 지원자 환영
- Dana Farber Cancer Institute, Boston
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
Prostate Cancer Genetic Risk Evaluation and Screening Study
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
다른 도시의 전립선암 시험
- New York City, NY연구 103개
- Houston, TX연구 76개
- Los Angeles, CA연구 61개
- St. Louis, MO연구 47개
- San Francisco, CA연구 45개
- Chicago, IL연구 45개
- Seattle, WA연구 44개
- Philadelphia, PA연구 44개
- Nashville, TN연구 43개
- Baltimore, MD연구 42개
- Washington, DC연구 38개
- Dallas, TX연구 36개
Boston의 다른 연구
- 유방암연구 110개
- 비소세포폐암연구 89개
- 암 (전체)연구 86개
- 대장직장암연구 63개
- 전이성 암연구 63개
- 폐암연구 62개
- 난소암연구 61개
- 우울증연구 51개
- 자궁내막암연구 50개
- 급성 골수성 백혈병연구 45개
- 췌장암연구 44개
- 심부전연구 43개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.